ViroCell Biologics
Home
Conferences Careers Contact Us
Leadership Team Scientific Advisory Board Board of Directors
Innovation Research Vector design & optimization Process Development GMP manufacturing
In the News Press Releases
Home Who We Are Leadership Team Scientific Advisory Board Board of Directors What we do Innovation Research Vector design & optimization Process Development GMP manufacturing
ViroCell Biologics
Conferences Newsroom In the News Press Releases CareersContact Us
Hired and retired: New appointments in the biopharma industry

Virocell Biologics: New COO.

READ MORE
Florence BuchananDecember 2, 2022CDMO, UK CDMO, ViroCell, gene therapy, cell and gene therapies, cell therapy, viral vector, viral vectors, New hires, Nick Maishman
LinkedIn0 0 Likes
Previous

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

Florence BuchananDecember 16, 2022
Next

ViroCell strengthens senior management team with appointment of Nick Maishman as COO

In the NewsFlorence BuchananNovember 22, 2022viral vectors, UK CDMO, CDMO, gene therapy, cell therapy, clinical trials, cell and gene therapies, Nick Maishman, ViroCell, Pharmiweb.com
NewsroomCareersContact UsTerms of UsePrivacy Notice

London New York

 

©2024 ViroCell Biologics, Ltd. All rights reserved.